| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |